http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746110-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4cd9a2ae528abb61034e08fa7c2d918
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2023-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae8ffcd264e309d8c44eee6022d67a71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b28f80aa41f1976c438bd35486ae0981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da3044eac224813411b3ef868c3e1c9f
publicationDate 2023-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11746110-B2
titleOfInvention Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activity
abstract Disclosed are alkynyl (hetero) aromatic ring compounds that inhibit protein tyrosine kinases, pharmaceutical compositions comprising same, preparations therefor and uses thereof. Specifically, disclosed are an alkynyl (hetero) aromatic ring compound represented by formula (I), and a pharmaceutically acceptable salt, a stereoisomer, a solvate, a hydrate, a crystal form, a prodrug or an isotope variant thereof. The disclosed compounds may be used in the treatment and/or prevention of diseases associated with protein tyrosine kinase, such as in preventing tumors.
priorityDate 2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014513078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013162727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9278971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016172117-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021070758-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009521462-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018033091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015514802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10870647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017222285-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014045826-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008027076-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015105377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014066434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103044432-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007075869-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014510154-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485353354

Total number of triples: 50.